Skip to main content
Log in

The inhibition of tyramine oxidation and the tyramine hypertensive response (“cheese effect”) may be independent phenomena

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Although the selective monoamine oxidase (MAO) inhibitor, (−)-deprenyl, substantially inhibits tyramine-oxidizing ability in the pig, intravenous tyramine challenge after pretreatment with this drug failed to produce the characteristic pressor response (“cheese effect”) associated with other irreversible MAO inhibitors. Conversely, pretreatment with the tyramine oxidation-sparing selective MAO inhibitor, clorgyline, followed by intravenous tyramine, paradoxically resulted in a profound pressor response. We suggest that the action of standard MAO-inhibiting drugs may be compounded of two separate actions, usually associated but, in fact, unrelated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Brown, G. L., Gillespie, J. S. The output of sympathetic transmitter from the spleen of the cat. J. Physiol. (Lond.)138, 81–102 (1957).

    Google Scholar 

  • Egashira, T., Ekstedt, B., Oreland, L. Inhibition of clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria. Biochem. Pharmacol.25, 2583–2586 (1976).

    PubMed  Google Scholar 

  • Ekstedt, B., Oreland, L. Heterogeneity of pig liver and pig brain mitochondrial monoamine oxidase. Arch. Int. Pharmacodyn.222, 157–165 (1976).

    PubMed  Google Scholar 

  • Elsworth, J. D., Glover, V., Reynolds, G. P., Sandler, M., Lees, A. J., Phuapradit, P., Shaw, K. M., Kumar, P. Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the “cheese effect”. Psychopharmacology57, 33–38 (1978).

    PubMed  Google Scholar 

  • Holt, M. C. Pargyline hydrochloride in essential hypertension. Br. J. clin. Pract.21, 447–453 (1967).

    PubMed  Google Scholar 

  • Iversen, L. L. The Uptake and Storage of Noradrenaline in Sympathetic Nerves. Cambridge: Cambridge University Press. 1967.

    Google Scholar 

  • Johnston, J. P. Some observations upon a new inhibitor of monoamine oxidase. Biochem. Pharmac.17, 1285–1297 (1968).

    Google Scholar 

  • Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors. In: Monoamine Oxidase and its Inhibition (Wolstenholme, G. E. W., Knight, J., eds.), pp. 135–161. Amsterdam: Elsevier Excerpta Medica-North Holland. 1976.

    Google Scholar 

  • Knoll, J., Magyar, K. Some puzzling pharmacological effects of monoamine oxidase inhibitors. In: Monoamine Oxidases-New Vistas (Costa, E., Sandler, M., eds.), pp. 393–408. New York: Raven Press. 1972.

    Google Scholar 

  • Lader, M. H., Sakalin, G., Tansella, M. Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor. Psychopharmacologia18, 117–123 (1970).

    Google Scholar 

  • Lee, K. Y., Beilin, L. J., Vandongen, R. Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin. Lanceti, 1110–1111 (1979).

    Google Scholar 

  • Lipper, S., Murphy, D. L., Slater, S., Buchsbaum, M. S. Comparative behavioral effects of clorgyline and pargyline. Psychopharmacology62, 123–128 (1979).

    PubMed  Google Scholar 

  • Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. Protein determinations with the Folin phenol reagent. J. biol. Chem.193, 265–275 (1951).

    PubMed  Google Scholar 

  • Marley, E. Monoamine oxidase inhibitors and drug interactions. In: Drug Interactions (Grahame-Smith, D. G., ed.), pp. 171–194. London: Macmillan. 1977.

    Google Scholar 

  • Mendis, N., Pare, C. M. B., Sandler, M., Glover, V., Stern, G. M.: Submitted for publication (1980).

  • Pickar, D., Cohen, R. M., Jimerson, D. C., Murphy, D. L.: Selective MAO A and MAO B inhibition and intravenous tyramine pressor sensitivity. Poster Session, 18th Annual Meeting, American College of Neuropsychopharmacology, San Juan, 1979.

  • Robinson, D. S., Lovenberg, W., Keiser, G., Sjoerdsma, A. Effects of drugs on human blood platelet and plasma amine oxidase activityin vitro andin vivo. Biochem. Pharmac.17, 109–119 (1968).

    Google Scholar 

  • Robinson, D. S., Nies, A., Ravaris, C. L., Lamborn, K. R. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive anxiety states. A controlled clinical trial. Arch. Gen. Psychiat.29, 407–413 (1973).

    PubMed  Google Scholar 

  • Simpson, L. L. Evidence that deprenyl, a type B monoamine oxidase inhibitor, is anindirectly acting sympathomimetic amine. Biochem. Pharmacol.27, 1591–1595 (1978).

    PubMed  Google Scholar 

  • Smith, C. K., Durack, D. T. Isoniazid and reaction to cheese. Ann. Int. Med.88, 520–521 (1978).

    PubMed  Google Scholar 

  • Squires, R. F. Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species. In: Monoamine Oxidases-New Vistas (Costa, E., Sandler, M., eds.), pp. 355–370. New York: Raven Press. 1972.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sandler, M., Glover, V., Ashford, A. et al. The inhibition of tyramine oxidation and the tyramine hypertensive response (“cheese effect”) may be independent phenomena. J. Neural Transmission 48, 241–247 (1980). https://doi.org/10.1007/BF01250659

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01250659

Keywords

Navigation